Product NDC: | 0095-7075 |
Proprietary Name: | Orbivan CF |
Non Proprietary Name: | acetaminophen and butalbital |
Active Ingredient(s): | 300; 50 mg/1; mg/1 & nbsp; acetaminophen and butalbital |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0095-7075 |
Labeler Name: | ECR Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090956 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120308 |
Package NDC: | 0095-7075-01 |
Package Description: | 100 TABLET in 1 BOTTLE (0095-7075-01) |
NDC Code | 0095-7075-01 |
Proprietary Name | Orbivan CF |
Package Description | 100 TABLET in 1 BOTTLE (0095-7075-01) |
Product NDC | 0095-7075 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | acetaminophen and butalbital |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120308 |
Marketing Category Name | ANDA |
Labeler Name | ECR Pharmaceuticals |
Substance Name | ACETAMINOPHEN; BUTALBITAL |
Strength Number | 300; 50 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Barbiturate [EPC],Barbiturates [Chemical/Ingredient] |